Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $83.1900 (1.49%) ($80.5960 - $84.2400) on Tue. Nov. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 48 | Latest Price | $83.1900(1.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND declines -0.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(50%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.255% in a week (0% probabilities). VIXM(-22%) UUP(-17%) VXX(-14%) UNG(-3%) EDOC(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $84.24 | 5 Day Moving Average | $83.48(-0.35%) | 10 Day Moving Average | $84.28(-1.29%) | 20 Day Moving Average | $84.24(-1.25%) | To recent high | -28.5% | To recent low | 3.5% | Market Cap | $1.337b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |